文献速递血栓与止血

静脉血栓栓塞症抗凝治疗临床研究中致命性出血的定义:范围综述

Definitions of fatal bleeding in clinical studies evaluating anticoagulant treatment for venous thromboembolism: A scoping review.
PubMed 文献 · J Thromb Haemost · 2023-02-28

本范围综述检索2008年1月至2021年7月MEDLINE、Embase和CENTRAL数据库,纳入132篇文章(代表89项独立研究),总结静脉血栓栓塞症抗凝治疗研究中致命性出血的定义及大出血病死率。仅27篇(20%)文章和89项研究中的7项(8%)报告了致命性出血定义,共识别3类定义;大出血病死率范围为0至60%(中位数9.1%,四分位距2.8%-18%)。

要点

  • 仅20%文章和8%研究报告了致命性出血定义,共识别3类定义。
  • 大出血病死率范围为0至60%,中位数9.1%(四分位距2.8%-18%)。
  • 缺乏标准化致命性出血定义可能导致风险评估不准确,尤其跨研究比较时。

核心结论

  • 不到10%的静脉血栓栓塞症抗凝治疗研究报告了致命性出血定义,缺乏标准化定义可能导致致命性出血风险估计不准确,尤其跨研究比较时。

研究设计与样本

  • 范围综述,检索MEDLINE、Embase和CENTRAL数据库2008年1月至2021年7月的前瞻性研究,纳入静脉血栓栓塞症患者并评估抗凝疗效/安全性或以致命性或大出血为主要结局的研究。
  • 由两名作者独立进行研究选择和数据提取,纳入132篇文章代表89项独立研究,采用描述性统计分析。

主要发现

  • 4911条记录中纳入132篇文章代表89项独立研究。
  • 27篇(20%)文章和89项研究中的7项(8%)报告了致命性出血定义。
  • 共识别3类致命性出血定义:基于出血与死亡之间的特定时间间隔、基于出血部位(颅内)或临床表现(血流动力学恶化)、或主要依赖裁定委员会判断死亡原因。
  • 大出血病死率范围为0至60%(中位数9.1%,四分位距2.8%-18%)。

关键数值与推荐

  • 致命性出血定义共3类:基于出血与死亡之间的特定时间间隔、基于出血部位(颅内)或临床表现(血流动力学恶化)、或主要依赖裁定委员会判断死亡原因。
  • 大出血病死率范围为0至60%,中位数9.1%,四分位距2.8%-18%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Fatal bleeding is a component of the primary safety outcome in most studies evaluating anticoagulation for venous thromboembolism (VTE), but a standardized definition for fatal bleeding is lacking. OBJECTIVES: To summarize definitions of fatal bleeding and describe the range of case-fatality rates of major bleeding in VTE studies. METHODS: MEDLINE, Embase, and CENTRAL databases were searched from January 2008 to July 2021 for prospective studies that enrolled patients with VTE and evaluated the efficacy/safety of anticoagulation for VTE treatment or included fatal or major bleeding as primary outcome. Two authors independently performed study selection and data extraction. The primary outcome was the definition of fatal bleeding. The secondary outcome was the case-fatality rate of major bleeding. Data were analyzed using descriptive statistics. RESULTS: Of 4911 records identified, we included 132 articles representing 89 distinct studies. Twenty-seven (20%) articles and 7 of 89 (8%) studies reported a definition of fatal bleeding. Overall, we identified 3 different types of definitions that were either on the basis of a specific time interval between bleeding and death, bleeding location (intracranial) or clinical presentation (hemodynamic deterioration), or mainly relied on the judgment of the adjudication committee to determine the cause of death. The case-fatality rate of major bleeding ranged from 0 to 60% (median, 9.1%; interquartile range, 2.8%-18%). CONCLUSION: Less than 10% of studies assessing anticoagulant treatment for VTE reported a definition for fatal bleeding. The lack of a (standardized) definition for fatal bleeding may lead to inaccurate estimates of the risk of fatal bleeding, particularly when compared across studies.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Schenker C, Marx CE, Kraaijpoel N, et al. Definitions of fatal bleeding in clinical studies evaluating anticoagulant treatment for venous thromboembolism: A scoping review. J Thromb Haemost. 2023. PMID: 36858345. doi:10.1016/j.jtha.2023.02.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。